With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Dividend growth and low payout ratios are key for long-term compounding. Click here for more information on Dividend ...

Hims & Hers continues to deliver strong subscriber and revenue growth, with Q1 2025 revenue up 111% YoY. Check out why I ...

China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most Favored Nation executive order; FDA Commissioner Marty Makary and CBER director ...

When Page Campbell's doctor recommended she try an injectable prescription drug called Wegovy to lose weight before ...

The Trump administration announced it will not finalize a rule proposed by the Biden administration that would have allowed ...

Article originally published by. FE fundinfo is not responsible for its content or accuracy and may not share the author’s views. News and research are not personal recommendations to deal. All ...

The recent decision by some US states to cover glucagon-like peptide-1 (GLP-1) agonists for obesity treatment marks a shift ...

Kenya is among the low- and middle-income countries (LMICs) whose children and young people (CYP) face gross inequities when ...

The Novo Nordisk Foundation has pledged up to DKK 380 million ($57.76 million) to the World Health Organization (WHO) to ...

Despite the boost to contributions, WHO has downsized its 2026-27 budget by over $1bn due to financial constraints.

KDA Group Inc. ("KDA" or the "Corporation"), a leader in innovative technological solutions for healthcare professionals, is pleased to announce that its Adherize+ platform, designed to optimize ...